"Omnitrope is reported to be the first version of a previously approved recombinant biotechnology drug to be approved by Health Canada under the regulatory term 'subsequent entry biologic'. "
"Omnitrope costs up to 40% less on a per mg basis than other leading growth hormone products"
Of course that still makes it way more pricey than the leading Chinese alternatives.
No comments:
Post a Comment